within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01E_ProteinKinaseInhibitors.L01EB01_Gefitinib;

model Gefitinib
  extends Pharmacolibrary.Drugs.ATC.L.L01EB01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>L01EB01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Gefitinib is an oral, selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor used primarily in the treatment of non-small cell lung cancer (NSCLC) harboring EGFR mutations. It is approved and widely used for advanced NSCLC therapy.</p><h4>Pharmacokinetics</h4><p>Typical pharmacokinetic parameters in adult patients with solid tumors receiving oral gefitinib; median age about 60 years; both sexes; no significant renal/hepatic impairment.</p><h4>References</h4><ol><li><p>Rahman, AF, et al., &amp; Kassem, MG (2014). Gefitinib. <i>Profiles of drug substances, excipients, and related methodology</i> 39 239–264. DOI:<a href=\"https://doi.org/10.1016/B978-0-12-800173-8.00005-2\">10.1016/B978-0-12-800173-8.00005-2</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/24794908/\">https://pubmed.ncbi.nlm.nih.gov/24794908</a></p></li><li><p>Culy, CR, &amp; Faulds, D (2002). Gefitinib. <i>Drugs</i> 62(15) 2237–2250. DOI:<a href=\"https://doi.org/10.2165/00003495-200262150-00008\">10.2165/00003495-200262150-00008</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12381224/\">https://pubmed.ncbi.nlm.nih.gov/12381224</a></p></li><li><p>Yasumuro, O, et al., &amp; Namiki, N (2018). Changes in gefitinib, erlotinib and osimertinib pharmacokinetics under various gastric pH levels following oral administration of omeprazole and vonoprazan in rats. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 48(11) 1106–1112. DOI:<a href=\"https://doi.org/10.1080/00498254.2017.1396379\">10.1080/00498254.2017.1396379</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29057719/\">https://pubmed.ncbi.nlm.nih.gov/29057719</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Gefitinib;
